Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)
GlobeNewswire
Met primary study endpoints: good safety profile and reduction in central subfield thickness (CST)
First oral therapy to..